BVXV Annual Retained Earnings
-$115.83 M
-$5.80 M-5.27%
31 December 2022
Summary:
As of February 2, 2025, BVXV annual retained earnings is -$115.83 million, with the most recent change of -$5.80 million (-5.27%) on December 31, 2022. During the last 3 years, it has fallen by -$23.33 million (-25.22%).BVXV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Retained Earnings
-$123.11 M
-$3.76 M-3.15%
30 June 2023
Summary:
As of February 2, 2025, BVXV quarterly retained earnings is -$123.11 million, with the most recent change of -$3.76 million (-3.15%) on June 30, 2023. Over the past year, it has dropped by -$11.64 million (-10.44%).BVXV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.3% | -10.4% |
| 3 y3 years | -25.2% | -15.9% |
| 5 y5 years | -226.2% | -176.1% |
BVXV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +706.1% | +594.7% |
BiondVax Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -$123.11 M(+3.2%) |
| Mar 2023 | - | -$119.35 M(+3.0%) |
| Dec 2022 | -$115.83 M(+5.3%) | -$115.83 M(+7.7%) |
| Sept 2022 | - | -$107.54 M(-3.5%) |
| June 2022 | - | -$111.47 M(-5.2%) |
| Mar 2022 | - | -$117.63 M(+6.9%) |
| Dec 2021 | -$110.04 M(+8.9%) | -$110.04 M(+0.1%) |
| Sept 2021 | - | -$109.94 M(+3.8%) |
| June 2021 | - | -$105.96 M(+6.3%) |
| Mar 2021 | - | -$99.72 M(-1.3%) |
| Dec 2020 | -$101.01 M(+9.2%) | -$101.01 M(+12.1%) |
| Sept 2020 | - | -$90.10 M(-15.1%) |
| June 2020 | - | -$106.17 M(+17.0%) |
| Mar 2020 | - | -$90.75 M(-1.9%) |
| Dec 2019 | -$92.51 M(+65.0%) | -$92.51 M(+16.2%) |
| Sept 2019 | - | -$79.61 M(+10.3%) |
| June 2019 | - | -$72.18 M(+24.4%) |
| Mar 2019 | - | -$58.04 M(+3.5%) |
| Dec 2018 | -$56.06 M | -$56.06 M(+22.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -$45.77 M(+2.7%) |
| June 2018 | - | -$44.59 M(+13.8%) |
| Mar 2018 | - | -$39.19 M(+10.4%) |
| Dec 2017 | -$35.51 M(+53.7%) | -$35.51 M(+12.8%) |
| Sept 2017 | - | -$31.47 M(-2.3%) |
| June 2017 | - | -$32.22 M(+15.9%) |
| Mar 2017 | - | -$27.79 M(+20.3%) |
| Dec 2016 | -$23.10 M(+13.2%) | -$23.10 M(+0.4%) |
| Sept 2016 | - | -$23.02 M(+5.6%) |
| June 2016 | - | -$21.80 M(+1.2%) |
| Mar 2016 | - | -$21.55 M(+5.6%) |
| Dec 2015 | -$20.41 M(+14.4%) | -$20.41 M(+5.0%) |
| Sept 2015 | - | -$19.45 M(-4.0%) |
| June 2015 | - | -$20.25 M(+12.3%) |
| Mar 2015 | - | -$18.03 M(+1.1%) |
| Dec 2014 | -$17.84 M(+0.7%) | -$17.84 M(-2.9%) |
| Sept 2014 | - | -$18.37 M(+3.7%) |
| Dec 2013 | -$17.72 M(+23.3%) | -$17.72 M |
| Dec 2012 | -$14.37 M | - |
FAQ
- What is BiondVax Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual retained earnings year-on-year change?
- What is BiondVax Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly retained earnings year-on-year change?
What is BiondVax Pharmaceuticals annual retained earnings?
The current annual retained earnings of BVXV is -$115.83 M
What is the all time high annual retained earnings for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual retained earnings is -$14.37 M
What is BiondVax Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, BVXV annual retained earnings has changed by -$5.80 M (-5.27%)
What is BiondVax Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of BVXV is -$123.11 M
What is the all time high quarterly retained earnings for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly retained earnings is -$17.72 M
What is BiondVax Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, BVXV quarterly retained earnings has changed by -$11.64 M (-10.44%)